These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12520875)

  • 21. Mucosal approaches to HIV vaccine development.
    Forrest BD
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1523-5. PubMed ID: 1466996
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of herpes and HIV co-infection.
    Freedman E; Mindel A
    J HIV Ther; 2004 Feb; 9(1):4-8. PubMed ID: 15071423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
    Hirbod T; Broliden K
    J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive health.
    Whaley KJ; Zeitlin L
    Vaccine; 2005 Mar; 23(15):1819-22. PubMed ID: 15734048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing the spread of herpes genitalis.
    Yabrov A
    Lancet; 1977 Apr; 1(8015):809-10. PubMed ID: 66612
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.
    Behling J; Chan AK; Zeh C; Nekesa C; Heinzerling L
    PLoS One; 2015; 10(5):e0128370. PubMed ID: 26010772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors facilitating the sexual transmission of HIV-1.
    Sullivan AK; Atkins MC; Boag F
    AIDS Patient Care STDS; 1997 Jun; 11(3):167-77. PubMed ID: 11361790
    [No Abstract]   [Full Text] [Related]  

  • 28. Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines.
    Mestecky J; Jackson S
    J Clin Immunol; 1994 Sep; 14(5):259-72. PubMed ID: 7814455
    [No Abstract]   [Full Text] [Related]  

  • 29. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-reducing protein production and delivery for sexually transmitted disease prevention.
    Saltzman WM
    IEEE Eng Med Biol Mag; 2003; 22(1):43-8. PubMed ID: 12683061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.
    Venkatesh KK; Cu-Uvin S
    Am J Reprod Immunol; 2014 Jun; 71(6):495-504. PubMed ID: 24832617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.
    Byrne CM; Gantt S; Coombs D
    PLoS Comput Biol; 2018 Apr; 14(4):e1006129. PubMed ID: 29698393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of genital herpes (HSV-2) infections.
    Burt JL
    R Soc Health J; 1979 Feb; 99(1):31. PubMed ID: 581706
    [No Abstract]   [Full Text] [Related]  

  • 35. Sexually transmitted herpes simplex viruses.
    Jonsson MK; Wahren B
    Scand J Infect Dis; 2004; 36(2):93-101. PubMed ID: 15061661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.
    Ghosh M
    Am J Reprod Immunol; 2014 Jun; 71(6):575-88. PubMed ID: 24754244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoprophylaxis against mother-to-child transmission of HIV-1.
    Gorny MK; Zolla-Pazner S
    PLoS Med; 2006 Jul; 3(7):e259. PubMed ID: 16842019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of mucosal immunity in prevention of HIV transmission.
    Kozlowski PA; Neutra MR
    Curr Mol Med; 2003 May; 3(3):217-28. PubMed ID: 12699359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genital herpes simplex virus type 1 infection--variability in modes of spread.
    Dolin R; Gill FA; Nahmias AJ
    J Am Vener Dis Assoc; 1975 Dec; 2(2):13-6. PubMed ID: 173699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active and passive immunization against HIV type 1 infection in chimpanzees.
    Murthy KK; Cobb EK; Rouse SR; McClure HM; Payne JS; Salas MT; Michalek GR
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S271-6. PubMed ID: 9814955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.